Our experiments suggest that chemerin could be a therapeutic target in the treatment of inflammatory diseases, particularly RA, in which chemerin has consistently been implicated in the pathology of this disease (16, 19, 54, 70). The gene discussed is RARRES2; the disease is rheumatoid arthritis.